Table 2.
Variables | Total study population | 23–25 weeks of gestation group | 26–29 weeks of gestation group | ||||||
---|---|---|---|---|---|---|---|---|---|
Male (n = 1118) | Female (n = 1045) | P | Male (n = 311) | Female (n = 292) | P | Male (n = 807) | Female (n = 753) | P | |
Multiple births | 367 (32.8) | 336 (32.2) | 0.738 | 126 (40.5) | 101 (34.6) | 0.133 | 241 (29.9) | 235 (31.2) | 0.564 |
Maternal diabetes | 98 (8.8) | 73 (7.0) | 0.125 | 17 (5.5) | 14 (4.8) | 0.709 | 81 (10.0) | 59 (7.8) | 0.709 |
Maternal hypertension | 117 (10.5) | 139 (13.3) | 0.041 | 17 (5.5) | 19 (6.5) | 0.590 | 100 (12.4) | 120 (15.9) | 0.044 |
Chorioamnionitis | 386 (34.5) | 351 (33.6) | 0.646 | 151 (48.6) | 129 (44.2) | 0.282 | 235 (29.1) | 222 (29.5) | 0.875 |
Antenatal steroid | 881 (78.8) | 825 (78.9) | 0.934 | 235 (75.6) | 217 (74.3) | 0.724 | 646 (80.0) | 608 (80.7) | 0.730 |
Data are presented as n (%).